Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
The present disclosure relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1, Ivacaftor), pharmaceutical compositions thereof and methods therewith. The compounds are useful in the treatment of CFTR-mediated diseases such...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | JOHNSTON STEVEN C KRAWIEC MARIUSZ SULLIVAN MARK JEFFREY MUDUNURI PRAVEEN MEDEK ALES AREKAR SNEHA G |
| description | The present disclosure relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1, Ivacaftor), pharmaceutical compositions thereof and methods therewith. The compounds are useful in the treatment of CFTR-mediated diseases such as cystic fibrosis. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ602557A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ602557A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ602557A3</originalsourceid><addsrcrecordid>eNrjZEgNzs_JTFFIyy_KVchPU8jTjTbSMdFNyizWMNQx1E3JzE0tyajMAROauqa6GZUpRfkVlQUZqXmVObG6hkC1KZlgQV0T3fyK_MLSzDyggXmpusa6yYlFSfkVibmZKak8DKxpiTnFqbxQmptBzs01xNlDN7UgPz61uCAxOTUvtSTeL8rMwMjU1NzRmKACAFeKO-Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide</title><source>esp@cenet</source><creator>JOHNSTON STEVEN C ; KRAWIEC MARIUSZ ; SULLIVAN MARK JEFFREY ; MUDUNURI PRAVEEN ; MEDEK ALES ; AREKAR SNEHA G</creator><creatorcontrib>JOHNSTON STEVEN C ; KRAWIEC MARIUSZ ; SULLIVAN MARK JEFFREY ; MUDUNURI PRAVEEN ; MEDEK ALES ; AREKAR SNEHA G</creatorcontrib><description>The present disclosure relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1, Ivacaftor), pharmaceutical compositions thereof and methods therewith. The compounds are useful in the treatment of CFTR-mediated diseases such as cystic fibrosis.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140926&DB=EPODOC&CC=NZ&NR=602557A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140926&DB=EPODOC&CC=NZ&NR=602557A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JOHNSTON STEVEN C</creatorcontrib><creatorcontrib>KRAWIEC MARIUSZ</creatorcontrib><creatorcontrib>SULLIVAN MARK JEFFREY</creatorcontrib><creatorcontrib>MUDUNURI PRAVEEN</creatorcontrib><creatorcontrib>MEDEK ALES</creatorcontrib><creatorcontrib>AREKAR SNEHA G</creatorcontrib><title>Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide</title><description>The present disclosure relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1, Ivacaftor), pharmaceutical compositions thereof and methods therewith. The compounds are useful in the treatment of CFTR-mediated diseases such as cystic fibrosis.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZEgNzs_JTFFIyy_KVchPU8jTjTbSMdFNyizWMNQx1E3JzE0tyajMAROauqa6GZUpRfkVlQUZqXmVObG6hkC1KZlgQV0T3fyK_MLSzDyggXmpusa6yYlFSfkVibmZKak8DKxpiTnFqbxQmptBzs01xNlDN7UgPz61uCAxOTUvtSTeL8rMwMjU1NzRmKACAFeKO-Q</recordid><startdate>20140926</startdate><enddate>20140926</enddate><creator>JOHNSTON STEVEN C</creator><creator>KRAWIEC MARIUSZ</creator><creator>SULLIVAN MARK JEFFREY</creator><creator>MUDUNURI PRAVEEN</creator><creator>MEDEK ALES</creator><creator>AREKAR SNEHA G</creator><scope>EVB</scope></search><sort><creationdate>20140926</creationdate><title>Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide</title><author>JOHNSTON STEVEN C ; KRAWIEC MARIUSZ ; SULLIVAN MARK JEFFREY ; MUDUNURI PRAVEEN ; MEDEK ALES ; AREKAR SNEHA G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ602557A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JOHNSTON STEVEN C</creatorcontrib><creatorcontrib>KRAWIEC MARIUSZ</creatorcontrib><creatorcontrib>SULLIVAN MARK JEFFREY</creatorcontrib><creatorcontrib>MUDUNURI PRAVEEN</creatorcontrib><creatorcontrib>MEDEK ALES</creatorcontrib><creatorcontrib>AREKAR SNEHA G</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JOHNSTON STEVEN C</au><au>KRAWIEC MARIUSZ</au><au>SULLIVAN MARK JEFFREY</au><au>MUDUNURI PRAVEEN</au><au>MEDEK ALES</au><au>AREKAR SNEHA G</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide</title><date>2014-09-26</date><risdate>2014</risdate><abstract>The present disclosure relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1, Ivacaftor), pharmaceutical compositions thereof and methods therewith. The compounds are useful in the treatment of CFTR-mediated diseases such as cystic fibrosis.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_NZ602557A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T05%3A20%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JOHNSTON%20STEVEN%20C&rft.date=2014-09-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ602557A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |